ADIPOQ and obesity disorder: Another adipokine, adiponectin has been shown to have an opposite effect to leptin in inflammation and insulin resistance, and the ratio of leptin to adiponectin is considered as a marker for developing T2D and obesity (Forny-Germano et al., 2018).